4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0001209191-21-070994
Chief Executive Officer acquired 17,750 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kulkarni Samarth Chief Executive Officer | 2021-12-20 | Option exercise | +17,750 | $1.81 | $32,128 | 279,085 | D |
| Derivatives | |||||||
| Kulkarni Samarth Chief Executive Officer | 2021-12-20 | Option exercise · Stock Option (Right to Buy) | −17,750 | 58,233 | D | ||
Loading xslF345X03/doc4.xml…